Status:
COMPLETED
Effectiveness of New Analgesic Strategy Compared to the Usal Antalgic Strategy
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Sickle Cell Anemia
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
Quality of life of adult patients with sickle cell disease is deeply impaired by severe adverse medical events that inadvertently occur throughout their time life. Indeed, patients not presenting a li...
Detailed Description
Purpose of the study: The main objective is to evaluate the effectiveness of an optimized combination of analgesic therapies for treating uncomplicated sickle cell disease crisis at initial visit to ...
Eligibility Criteria
Inclusion
- male adult patient with sickle cell anemia,
- age ≥ 18 years,
- main complaint : sickle cell crisis pain,
- initial numeric pain intensity scale at presentation \> 4,
- admission to the ED during working hours (amendment n°2-15/02/2010:from 8h to 20h), from Monday to Friday
Exclusion
- female adult patient
- complicated sickle cell crisis or admission requirement to an ICU
- recent hospitalisation (\< 10 days) for the same complaint
- previous inclusion in the study
- contraindication to anyone of the study drugs
- no medical insurance
- incompetent adult
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2012
Estimated Enrollment :
176 Patients enrolled
Trial Details
Trial ID
NCT00874172
Start Date
October 1 2009
End Date
November 1 2012
Last Update
December 18 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henri Mondor Hospital, Emergency Department
Créteil, France, 94000